FDA seeks to remove Endo's opioid pain medication from market

The FDA’s request marks the first time the agency has tried to get an opioid pain medication off the market because of the public health consequences of abuse.

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us